Biogen Inc. (BIIB) Lifted to Buy at ValuEngine


BIIB has been the topic of several other reports. Sanford C. Bernstein restated an "outperform" rating and set a $310.00 price objective on shares of Biogen in a research report on Friday, February 24th.



from Biotech News